Breaking News Instant updates and real-time market news.

APTI

Apptio

$36.60

-0.14 (-0.38%)

, BNFT

Benefitfocus

$37.60

0.55 (1.48%)

05:29
07/19/18
07/19
05:29
07/19/18
05:29

Jefferies expects rally in Software stocks to continue

Jefferies analyst John DiFucci thinks June quarter results in the Software space "could be relatively strong." The analyst estimates that the currency translation impact for the average software company should be a weaker tailwind than when guidance was given, resulting in a headwind of approximately 180 basis points. He expects the "meaningful, warranted appreciation" in some stocks to continue and raised his price targets accordingly. DiFucci upped his price target for Apptio (APTI) to $43 from $36, for Benefitfocus (BNFT) to $43 from $35, for Check Point (CHKP) to $127 from $117, for Tableau (DATA) to $100 from $87, for Nice Systems (NICE) to $127 from $119, for RingCentral (RNG) to $95 from $91, and for Varonis (VRNS) to $92 from $77. All stocks except Hold-rated Tableau are Buy rated by the analyst.

APTI

Apptio

$36.60

-0.14 (-0.38%)

BNFT

Benefitfocus

$37.60

0.55 (1.48%)

CHKP

Check Point

$110.69

0.58 (0.53%)

DATA

Tableau

$111.20

0.92 (0.83%)

NICE

Nice

$109.97

0.85 (0.78%)

RNG

RingCentral

$83.00

1.225 (1.50%)

VRNS

Varonis

$78.90

0.35 (0.45%)

  • 25

    Jul

  • 30

    Jul

  • 01

    Aug

  • 02

    Aug

  • 02

    Aug

  • 06

    Aug

  • 16

    Aug

  • 13

    Sep

  • 14

    Sep

APTI Apptio
$36.60

-0.14 (-0.38%)

04/27/18
JPMS
04/27/18
DOWNGRADE
Target $27
JPMS
Neutral
Apptio downgraded to Neutral on valuation at JPMorgan
JPMorgan analyst Mark Murphy downgraded Apptio to Neutral from Overweight with an unchanged price target of $27. The analyst views the risk/reward as more fairly balanced at valuation current levels. He cites valuation for the downgrade, and says the company's Q1 report will likely be "fine."
05/01/18
JEFF
05/01/18
NO CHANGE
Target $36
JEFF
Buy
Apptio price target raised to $36 from $33 at Jefferies
Jefferies analyst John DiFucci raised his price target for Apptio to $36 saying the company in Q1 exceeded expectations and posted accelerating subscription growth. The "numbers are set up well" for fiscal 2018 with a "prudent amount of conservatism implied," DiFucci tells investors in a post-earnings research note. He maintains a Buy rating on the shares.
07/10/18
KEYB
07/10/18
DOWNGRADE
KEYB
Sector Weight
Apptio downgraded to Sector Weight from Overweight at KeyBanc
07/10/18
07/10/18
DOWNGRADE

Sector Weight
Apptio downgraded to Sector Weight on valuation at KeyBanc
As previously reported, KeyBanc analyst Rob Owens downgraded Apptio to Sector Weight from Overweight as valuation limits upside potential. Although the analyst acknowledges that the stock's run over the past year stands justified as a reflection of solid execution on improving deployment times and broadening the value proposition, he believes the stock is now fully valued.
BNFT Benefitfocus
$37.60

0.55 (1.48%)

06/28/18
PIPR
06/28/18
NO CHANGE
Target $40
PIPR
Overweight
Benefitfocus price target raised to $40 from $31 at Piper Jaffray
Piper Jaffray analyst Sean Wieland raised his price target for Benefitfocus to $40 citing improved sales execution and visibility for 2019. The analyst believes "strong" bookings and new carriers announced on the upcoming Q2 earnings call could drive upside to the second half of 2018 outlook and "further de-risk" 2019. He increased his 2019 revenue growth estimate to 12% from 10% and reiterates an Overweight rating on Benefitfocus.
05/16/18
WELS
05/16/18
NO CHANGE
Target $38
WELS
Outperform
Benefitfocus price target raised to $38 from $30 at Wells Fargo
Wells Fargo analyst Jamie Stockton raised his price target for Benefitfocus to $38 from $30 following quarterly results. The analyst reiterates an Outperform rating on the shares.
05/04/18
BREN
05/04/18
NO CHANGE
Target $35
BREN
Buy
Benefitfocus price target raised to $35 from $29 at Berenberg
Berenberg analyst Robert Lamb raised his price target for Benefitfocus to $35 saying investors should look through the Q2 guidance miss, which he attributes to accounting changes. With two successive quarters of "significant" new customer wins, the equity story is de-risking and market sentiment is improving, Lamb tells investors in a post-earnings research note. He reiterates a Buy rating on Benefitfocus.
05/04/18
RBCM
05/04/18
UPGRADE
Target $40
RBCM
Outperform
Benefitfocus upgraded to Outperform at RBC Capital on improved sales execution
As reported earlier, RBC Capital analyst Ross MacMillan upgraded Benefitfocus to Outperform from Sector Perform and raised his price target to $40 from $32, saying the company's "improved sales execution" in the employer segment and greater revenue in voluntary product distribution has added more clarity to its financials. MacMillan further cites to the company's high gross margin in recurring revenue and growing free cash flows along with an "appealing" valuation.
CHKP Check Point
$110.69

0.58 (0.53%)

07/06/18
OTRG
07/06/18
UPGRADE
OTRG
Positive
Check Point upgraded to Positive from Mixed at OTR Global
07/06/18
07/06/18
UPGRADE

Check Point upgraded to Positive following checks at OTR Global
As previously reported, OTR Global upgraded Check Point to Positive from Mixed following checks that indicate strong Q2 sales trends year-over-year. The firm's analyst said European refreshes and strong sales in China and Australia have led to stabilizing win rates in Q2 after weakening in Q, but notes execution and longer-term cloud issues remain a concern.
07/10/18
BTIG
07/10/18
UPGRADE
BTIG
Buy
Check Point upgraded to Buy from Neutral at BTIG
07/10/18
BTIG
07/10/18
UPGRADE
Target $120
BTIG
Buy
Check Point upgraded to Buy at BTIG on higher salesforce effectiveness
As reported earlier, BTIG analyst Joel Fishbein upgraded Check Point to Buy from Neutral with a price target of $120, saying this is an appropriate time to get more constructive on the stock following 3 quarters of underperformance. The analyst cites growing evidence of "increased salesforce effectiveness" and "signals of a trough in expectations". Fishbein also contends that Check Point offers "incredible operating margins" of about 53% and an attractive free cash flow yield of about 7%, which has matched the "great year" for the cybersecurity sector.
DATA Tableau
$111.20

0.92 (0.83%)

07/11/18
KEYB
07/11/18
UPGRADE
KEYB
Overweight
Tableau upgraded to Overweight from Sector Weight at KeyBanc
07/11/18
07/11/18
UPGRADE
Target $125

Overweight
Tableau upgraded to Overweight on improving fundamentals at KeyBanc
As previously reported, KeyBanc analyst Brent Bracelin upgraded Tableau to Overweight from Sector Weight, with a $125 price target, on the prospects of improving fundamentals in 2H18 and into 2019. The analyst has increasing confidence that free cash flow could bottom during Q2 and reaccelerate in 2H18 as subscription revenue approaches 70% of the license mix versus 28% last year.
07/16/18
STFL
07/16/18
NO CHANGE
Target $120
STFL
Buy
Tableau price target raised to $120 after checks inspire confidence at Stifel
Stifel analyst Tom Roderick said his checks indicate that the demand environment remains very steady for Tableau give him confidence to raise his price target on the stock to $120 from $115 ahead of the company's earnings report scheduled for August 2. He expects the favorable trend in the mix of ratable license bookings that was evident in Q1 to continue in Q2, Roderick noted. He maintains a Buy rating on Tableau shares.
07/18/18
UBSW
07/18/18
NO CHANGE
Target $114
UBSW
Buy
Tableau can continue higher despite year-to-date move, says UBS
UBS analyst Jennifer Swanson Lowe noted Tableau shares have rallied 60% year-to-date as the company executes on its model transition, but she sees potential for the shares to continue to move higher. The analyst said her checks show strong demand trends and increasing subscription adoption. She anticipates solid Q2 results with greater upside in the second half of the year. Lowe reiterated her Buy rating and $114 price target on Tableau shares.
NICE Nice
$109.97

0.85 (0.78%)

05/11/18
05/11/18
DOWNGRADE

Market Perform
JMP downgrades Mattersight to Market Perform after merger background disclosed
As previously reported, JMP Securities analyst Patrick Walravens downgraded Mattersight (MATR) to Market Perform from Outperform after the company filed its Form SC 14D9 related to its agreement to be acquired by Nice Systems (NICE). The form showed that Nice had initially submitted an offer of $3.32 per share, although it revised this offer downward to $2.70 on April 20 after conducting due diligence that revealed risks around customer attrition and a bookings shortfall in Q1, noted Walravens.
05/16/18
JEFF
05/16/18
NO CHANGE
Target $119
JEFF
Buy
Nice Systems price target raised to $119 from $112 at Jefferies
Jefferies analyst John DiFucci raised his price target for Nice Systems to $119 and maintains a Buy rating on the shares. The analyst left the company's user conference with more confidence its business is "on the upswing." Nice represents an underappreciated asset at an attractive price, DiFucci tells investors in a research note. He encourages investors "looking for value and accelerating growth" to buy the stock at current levels.
05/17/18
OPCO
05/17/18
NO CHANGE
Target $115
OPCO
Outperform
Nice at the forefront of technologies set to drive growth, says Oppenheimer
Oppenheimer analyst Shaul Eyal reiterated an Outperform rating and $115 price target on Nice following the company's "upbeat" investor day. In a research note to investors, Eyal said that the company remains at the forefront of the advanced technologies that are set to drive growth, adding that the company is increasingly incorporating automation into its solutions that could create significant value.
06/22/18
DADA
06/22/18
INITIATION
Target $110
DADA
Neutral
Nice Systems initiated with a Neutral at DA Davidson
DA Davidson analyst Rishi Jaluria initiated Nice Systems with a Neutral rating and a price target of $110, saying he is positive on the company's market leadership position in the cloud and the ongoing operational improvements under CEO Eilam leading to rising operating margins. The analyst believes that the stock is fairly valued however, opting to await a pullback in price for a more constructive stance.
RNG RingCentral
$83.00

1.225 (1.50%)

07/11/18
STFL
07/11/18
INITIATION
Target $100
STFL
Buy
RingCentral initiated with a Buy at Stifel
Stifel analyst Matthew Van Vliet initiated RingCentral with a Buy rating and a price target of $100, saying the company is positioned as a leading provider of cloud-native communications services for businesses of all sizes. Van Vliet notes that its market leadership has been increasing over the past few years, thanks to its broad portfolio approach "delivering essential communications channels" and enterprise-grade scalability. Van Vliet adds that the company's push into Enterprise market is accelerating its bookings growth and margin expansion.
06/19/18
OPCO
06/19/18
NO CHANGE
Target $92
OPCO
Outperform
RingCentral price target raised to $92 from $79 at Oppenheimer
Oppenheimer analyst Brian Schwartz raised his price target for RingCentral to $92 from $79 after attending the company's investors day. The analyst left the investors meeting feeling more comfortable in his RingCentral estimates and his large TAM and open-ended growth with improving operating profitability thesis. Schwartz reiterates an Outperform rating on the shares.
06/15/18
JPMS
06/15/18
NO CHANGE
Target $84
JPMS
Neutral
RingCentral price target raised to $84 from $76 at JPMorgan
JPMorgan analyst Sterling Auty raised his price target for RingCentral to $84 and maintains a Neutral rating on the shares following the company's investor day. The day focused on the themes of a large market that is still early in the penetration, Auty tells investors in a research note. He notes that management updated its 2020 goal stating they now expect to exceed $1B and with profitability that puts it above the rule of 40.
06/15/18
JEFF
06/15/18
NO CHANGE
Target $91
JEFF
Buy
RingCentral price target raised to $91 from $84 at Jefferies
Jefferies analyst John DiFucci raised his price target for RingCentral to $91 after attending the company's investor day. RingCentral now expects to exceed the previous 2020 revenue target of $1B, and implied margin expansion and commentary on the "rule of 40" implies 2020 revenue growth of roughly 30%, DiFucci tells investors in a research note. The analyst sees further penetration potential within the company's existing install base and reiterates a Buy rating on the shares.
VRNS Varonis
$78.90

0.35 (0.45%)

05/01/18
RBCM
05/01/18
NO CHANGE
Target $78
RBCM
Outperform
Varonis price target raised to $78 from $74 at RBC Capital
RBC Capital analyst Matthew Hedberg raised his price target on Varonis to $78 and kept his Outperform rating after the company's Q1 earnings beat, saying the company's strong start to FY18 was highlighted by revenue upside and increased profitability. The analyst notes the strong earnings were particularly driven by 60% growth in EMEA as well as increasing cross-selling opportunities, adding that the company's guidance also appears to be conservative given his "conviction" in long-term growth trends.
05/01/18
IMPC
05/01/18
NO CHANGE
Target $77
IMPC
Outperform
Varonis price target raised to $77 from $68 at Imperial Capital
Imperial Capital analyst Michael Kim raised his price target for Varonis Systems to $77 after the company posted Q1 results above his estimates. The company remains well positioned to benefit from broadening compliance into Europe's General Data Protection Regulation, while cloud migrations represent another key growth driver, Kim tells investors in a post-earnings research note. He keeps an Outperform rating on Varonis.
05/23/18
OPCO
05/23/18
NO CHANGE
Target $80
OPCO
Outperform
Varonis price target raised to $80 from $71 at Oppenheimer
Oppenheimer analyst Shaul Eyal raised his price target for Varonis to $80 from $71 following an investor meeting with the company's management. The analyst says Varonis has barely scratched the surface of its extensive market opportunity, and that the recent uptick in market demand for its solutions is being driven by customers' view of data security shifting from a "nice to have" product to a "must have" cybersecurity and compliance necessity. Further, he believes Varonis' remains well positioned to benefit from industry tailwinds and a healthy security spending environment. Eyal reiterates an Outperform rating on the shares.
07/17/18
NEED
07/17/18
NO CHANGE
Target $90
NEED
Buy
Varonis price target raised to $90 from $80 at Needham
Needham analyst Alex Henderson raised his price target on Varonis to $90 and kept his Buy rating, saying the company remains one of his "top security picks" for 2018. The analyst notes that Varonis performance is ahead of peer group averages, with better gross margin and cash flows, even though it trades around the median valuation of its peers, giving the stock price room for further appreciation. Henderson also believes the company is "one of the best positioned names to benefit from GDPR" start given its focus on knowing what customer data has been compromised and being able to report this to the customer and regulators.

TODAY'S FREE FLY STORIES

02:50
05/21/19
05/21
02:50
05/21/19
02:50
General news
FX Update: The dollar has traded firmer »

FX Update: The dollar has…

02:10
05/21/19
05/21
02:10
05/21/19
02:10
General news
Asian Market Wrap: »

Asian Market Wrap:…

OXY

Occidental Petroleum

$53.49

0.74 (1.40%)

21:25
05/20/19
05/20
21:25
05/20/19
21:25
Downgrade
Occidental Petroleum rating change at Wells Fargo »

Occidental Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

TIGR

UP Fintech

$5.63

-0.14 (-2.43%)

20:41
05/20/19
05/20
20:41
05/20/19
20:41
Hot Stocks
Interactive Brokers Group discloses 7.6% stake in UP Fintech »

IBGI acquired beneficial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TJX

TJX

$52.95

-0.08 (-0.15%)

, HD

Home Depot

$190.87

-1.66 (-0.86%)

20:25
05/20/19
05/20
20:25
05/20/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

TJX

TJX

$52.95

-0.08 (-0.15%)

HD

Home Depot

$190.87

-1.66 (-0.86%)

AZO

AutoZone

$978.78

-5.21 (-0.53%)

KSS

Kohl's

$62.95

-0.68 (-1.07%)

EV

Eaton Vance

$37.27

-0.535 (-1.42%)

JCP

J.C. Penney

$1.15

0.01 (0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 21

    May

  • 21

    May

  • 21

    May

  • 21

    May

  • 21

    May

  • 21

    May

  • 23

    May

  • 24

    May

  • 29

    May

  • 04

    Jun

  • 11

    Jun

JCOM

j2 Global

$86.48

-0.23 (-0.27%)

20:22
05/20/19
05/20
20:22
05/20/19
20:22
Hot Stocks
j2 Global CFO sells 10K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 05

    Jun

ATTO

Atento

$3.24

-0.14 (-4.14%)

19:58
05/20/19
05/20
19:58
05/20/19
19:58
Earnings
Atento sees FY19 revenue flat to up single digits »

The company sees sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 23

    May

ATTO

Atento

$3.24

-0.14 (-4.14%)

19:57
05/20/19
05/20
19:57
05/20/19
19:57
Earnings
Atento reports Q1 recurring EPS (6c), consensus 10c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 23

    May

ITCB

Itau Corpbanca

$12.95

(0.00%)

19:38
05/20/19
05/20
19:38
05/20/19
19:38
Hot Stocks
Itau Corpbanca dissolves subsidiary Corplegal »

Itau Corpbanca announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OCUL

Ocular Therapeutix

$3.36

-0.1 (-2.89%)

19:36
05/20/19
05/20
19:36
05/20/19
19:36
Recommendations
Ocular Therapeutix analyst commentary at Piper Jaffray »

Ocular Therapeutix price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jun

  • 10

    Nov

YGYI

Youngevity

$6.57

0.13 (2.02%)

, QFIN

360 Finance

$16.46

0.71 (4.51%)

18:55
05/20/19
05/20
18:55
05/20/19
18:55
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: …

YGYI

Youngevity

$6.57

0.13 (2.02%)

QFIN

360 Finance

$16.46

0.71 (4.51%)

ARWR

Arrowhead

$18.94

-0.52 (-2.67%)

TRIP

TripAdvisor

$44.93

-0.07 (-0.16%)

ASNA

Ascena Retail

$1.13

-0.125 (-9.96%)

KR

Kroger

$24.04

-0.18 (-0.74%)

SNAP

Snap

$11.19

-0.3 (-2.61%)

NDSN

Nordson

$130.42

-4.8 (-3.55%)

OCUL

Ocular Therapeutix

$3.36

-0.1 (-2.89%)

SWI

SolarWinds

$19.16

0.04 (0.21%)

MRCY

Mercury Systems

$72.85

-0.11 (-0.15%)

VNE

Veoneer

$18.89

0.02 (0.11%)

GH

Guardant Health

$78.29

2.13 (2.80%)

CVNA

Carvana

$67.17

-0.935 (-1.37%)

INSM

Insmed

$28.08

-1.08 (-3.70%)

VAR

Varian Medical

$130.48

-0.26 (-0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 21

    May

  • 21

    May

  • 21

    May

  • 21

    May

  • 21

    May

  • 21

    May

  • 21

    May

  • 22

    May

  • 22

    May

  • 23

    May

  • 31

    May

  • 03

    Jun

  • 05

    Jun

  • 05

    Jun

  • 11

    Jun

  • 11

    Jun

  • 12

    Jun

  • 13

    Jun

  • 18

    Jun

  • 23

    Jun

  • 10

    Nov

  • 22

    May

  • 22

    May

  • 23

    May

  • 23

    May

  • 23

    May

  • 23

    Jun

TOL

Toll Brothers

$37.52

-0.88 (-2.29%)

18:47
05/20/19
05/20
18:47
05/20/19
18:47
Hot Stocks
Toll Brothers acquires Sharp Residential, terms not disclosed »

Toll Brothers announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

18:45
05/20/19
05/20
18:45
05/20/19
18:45
General news
Breaking General news story  »

Federal Reserve Chairman…

TTWO

Take-Two

$102.94

-3.82 (-3.58%)

18:44
05/20/19
05/20
18:44
05/20/19
18:44
Hot Stocks
Take-Two CEO: Our job is to excite customers »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 29

    May

  • 06

    Jun

  • 08

    Jun

  • 10

    Jun

  • 10

    Jun

  • 10

    Jun

  • 11

    Jun

  • 12

    Jun

  • 13

    Nov

AAL

American Airlines

$30.96

-0.8 (-2.52%)

18:40
05/20/19
05/20
18:40
05/20/19
18:40
Periodicals
American Air asks court to halt alleged mechanics unions' slowdown, Reuters says »

American Airlines has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 29

    May

  • 12

    Jun

  • 12

    Jun

LWAY

Lifeway Foods

$2.75

0.05 (1.85%)

18:38
05/20/19
05/20
18:38
05/20/19
18:38
Earnings
Lifeway Foods reports Q1 EPS (2c) vs. 0c last year »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

WHLR

Wheeler REIT

$2.25

0.025 (1.13%)

18:31
05/20/19
05/20
18:31
05/20/19
18:31
Hot Stocks
Wheeler REIT chairman John Sweet to resign »

Wheeler Real Estate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$101.54

0.66 (0.65%)

, TGT

Target

$72.10

1.22 (1.72%)

18:03
05/20/19
05/20
18:03
05/20/19
18:03
Periodicals
Judge says Walmart, Target, Bed Bath must face suits over cotton, Reuters says »

U.S. District Judge…

WMT

Walmart

$101.54

0.66 (0.65%)

TGT

Target

$72.10

1.22 (1.72%)

BBBY

Bed Bath & Beyond

$14.48

-0.525 (-3.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 22

    May

  • 29

    May

  • 05

    Jun

  • 05

    Jun

  • 07

    Jun

  • 07

    Jun

  • 12

    Jun

  • 15

    Aug

  • 13

    Nov

QFIN

360 Finance

$16.46

0.71 (4.51%)

18:02
05/20/19
05/20
18:02
05/20/19
18:02
Earnings
360 Finance reports Q1 net income $117.5M, up 382% from last year »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

MRK

Merck

$78.86

0.15 (0.19%)

18:02
05/20/19
05/20
18:02
05/20/19
18:02
Hot Stocks
Merck falls after Keytruda trial does not meet OS primary endpoint »

Shares of Merck have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 31

    May

  • 03

    Jun

  • 17

    Jun

  • 20

    Jun

  • 20

    Jun

  • 16

    Jul

  • 30

    Jul

  • 06

    Aug

  • 20

    Sep

PRIM

Primoris

$20.26

-0.08 (-0.39%)

17:55
05/20/19
05/20
17:55
05/20/19
17:55
Hot Stocks
Primoris director sells 99.8K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BK

BNY Mellon

$45.97

-0.11 (-0.24%)

, LM

Legg Mason

$35.68

0.295 (0.83%)

17:44
05/20/19
05/20
17:44
05/20/19
17:44
Hot Stocks
BNY Mellon announces Ed Garden to step down from board of directors »

BNY Mellon (BK) announced…

BK

BNY Mellon

$45.97

-0.11 (-0.24%)

LM

Legg Mason

$35.68

0.295 (0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

DHR

Danaher

$130.33

-0.81 (-0.62%)

17:44
05/20/19
05/20
17:44
05/20/19
17:44
Hot Stocks
VP of Danaher Angela Lalor sells over $408K in company shares »

VP of Danaher Angela…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 07

    Nov

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$283.95

-2.03 (-0.71%)

17:43
05/20/19
05/20
17:43
05/20/19
17:43
Periodicals
Judge dismisses Trump request to block accounting subpoena, WSJ says »

U.S. District Judge Amit…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$283.95

-2.03 (-0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LM

Legg Mason

$35.68

0.295 (0.83%)

17:40
05/20/19
05/20
17:40
05/20/19
17:40
Hot Stocks
Legg Mason names Nelson Peltz, Ed Garden to board of directors »

Legg Mason announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.